Hamps Bio Ltd

Demat/remat status

• Regulation 74(5) not applicable; entire holding in demat form.
• No dematerialisation/rematerialisation requests were received during the period.

Hamps Bio Limited — Trading window closed from 1st October, 2026 till 48 hours after the announcement/declaration of unaudited Standalone and Consolidated Financial Results of the Company for half year ended on 30th September, 2026.

AGM Details

• Date and time: 9 September 2026, 12:00–13:00; physical AGM at registered office.
• Mode: Physical meeting.
• Record date: 3 September 2026.
• Postal ballot deadline: 9 September 2026.
• Shareholders on record: 337; attendees: promoters 9, public 2; no video attendees.

Resolutions & outcomes

• Adopt audited standalone and consolidated financial statements for FY ended 31 March 2026.
• Re-appoint Pallavi Herrik Shah as director; retires by rotation.
• Approve shifting of registered office within Gujarat under the same registrar.
• All resolutions passed with 100% votes in favour.

Dividend

• No dividend declared at the AGM.

Director changes

• Pallavi Herrik Shah re-appointed as director.
• No other director changes disclosed.

Auditors

• No auditor appointments or changes disclosed.

Material related party transactions

• No material related party transactions disclosed.

Other material approvals

• Shift of registered office approved.

Remuneration approvals

• Remuneration increase approved for Herrik Mountbaton Shah, Chairman and Managing Director, per Nomination and Remuneration committee recommendation.
• Remuneration increase approved for Shrenikkumar Mountkumar Shah, Whole Time Director, per Nomination and Remuneration committee recommendation.
• Remuneration increase approved for Mitali Shrenikkumar Shah, Chief Financial Officer, per Nomination and Remuneration committee recommendation.
• Remuneration increase approved for Pallavi Herrik Shah, Director, per Nomination and Remuneration committee recommendation.

AGM Details

• Date and time: 09 September 2026 at 12:00 PM IST; physical meeting at registered office.
• Meeting concluded at 01:00 PM IST.
• Remote e-voting available; ballot papers provided at the meeting.

Ordinary Business

• Adopt audited standalone and consolidated financial statements for the year ending 31 March 2026.
• Re-appointment of Pallavi Herrik Shah, who retires by rotation.

Special Business

• Approve shifting of registered office within Gujarat under the same RoC.

Voting/Results

• Results of voting to be announced to stock exchange and placed on the company website.

Financials

• Standalone revenue from operations: ₹851.65 lakhs.
• Consolidated revenue from operations: ₹847.46 lakhs.
• Standalone net loss after tax: ₹65.49 lakhs.
• Consolidated net loss after tax: ₹73.87 lakhs.
• Standalone EPS: ₹-0.75 per share.
• Dividend not declared for FY2025-26.

Operations & Capacity

• Ankleshwar and Bhatpore facilities strengthened; Surat production now full-fledged.
• Surat freeze-drying capacity added: 450 kg/day.
• 350 kVA solar power plant commissioned at Ankleshwar.
• Kosher certification obtained for Ankleshwar facility.
• Capacity utilization ~18 tons/month per plant (22 installed).

Capital & Dividends

• Bonus issue: 4,356,000 shares (1:1).
• Authorized capital increased to ₹10 crore.
• Paid-up capital ₹8.712 crore.

Governance & Board

• Radhika Kanodiya resigned as Independent Director on 23 Jun 2025.
• Shivali Rajpurohit appointed as Additional Director on 25 Aug 2025.
• Shivali Rajpurohit regularised as Independent Director on 24 Nov 2025.
• Pallavi Herrik Shah to be re-appointed as Director.
• Board met 10 times in FY2025-26; committees formed and reconstituted.

Strategy & Growth

• Strategic shift from manufacturing to consumer brands.
• Focus on FzyEzy and OxyNXT brands.
• Export expansion and international markets focus.

Risks & Outlook

• Risks include raw material price volatility and currency fluctuations.
• Tariffs/regulatory changes affecting exports pose risk.
• Seasonality of agricultural inputs may impact volumes.

Related Party Transactions

• Related party transactions disclosed; director remuneration and loans.
• Transactions with HSDL, V4U Healthcare, Adinath, Mahavir, and others.

AGM Details

• AGM on 9 September 2026 at 12:00 PM at the registered office; mode: in-person.

Key Decisions

• Approved Board Report for FY ended 31 March 2026.
• Approved the 19th AGM notice for FY2026 on Sept 9, 2026 at 12:00.
• Approved draft Annual Report for FY2026.
• Recommended ordinary resolution for re-appointment of Pallavi Herrik Shah.
• Shifting of registered office from Ankleshwar to Surat within Gujarat; subject to AGM approval.
• Appointed M/s Richa Goyal & Associates as Scrutinizer for AGM voting.
• Fixation of Cut-off Date for eligibility to vote on AGM resolutions.

Demat/remat status

• No dematerialisation/rematerialisation requests were received during the quarter ended 30 June 2026.
• Regulation not applicable as the entire holding is in demat form.

Key Managerial Personnel

• MD Herrik Mountbaton Shah designated Managing Director; contact details provided.
• Shrenikkumar Mountkumar Shah designated Whole-time Director.
• Mitali Shrenikkumar Shah designated Chief Financial Officer.
• Ravi Baheti designated Company Secretary and Compliance Officer.
• Contact details include email hamps.bio@gmail.com and phones 8000001113, 8000006663.
• Registered office Bharuch and corporate office Surat details.